Clinical trial information

Clinical trial information

【Terms of Use】

【Terms of Use】

 This webpage is based on data available from publicity accessible clinical trial registry sites and provides information about clinical trials to those who search it..

 The purpose of this website is to enhance Taisho transparency regarding its clinical trials (to disclose information). It is not intended to advertise or promote our product.

 This webpage does not recommend the use of any drug for purposes other than its indicated uses or for unapproved used. Physicians should always refer to the latest package insert before prescribing drugs, rather than relying on the information provided here.

 The clinical significance of the information related to the results of clinical trials for each patient should be determined by a physician experienced in treating  the disease or by a relevant healthcare professional. If you have questions about specific symptoms, please consult a physician or a relevant healthcare professional.

 Taisho strives to provide the most up to date information about all the clinical trials listed here. However, the information may not be current depending on the last up date of the website. The results of clinical trials shared here reflect the knowledge obtained as of its completion date. This website do not provide information about the most recent assessments of the drug’s safety or efficacy.

Be sure to understand and agree to our “Term of Uses” before viewing this webpage.

 This webpage is based on data available from publicity accessible clinical trial registry sites and provides information about clinical trials to those who search it..

 The purpose of this website is to enhance Taisho transparency regarding its clinical trials (to disclose information). It is not intended to advertise or promote our product.

 This webpage does not recommend the use of any drug for purposes other than its indicated uses or for unapproved used. Physicians should always refer to the latest package insert before prescribing drugs, rather than relying on the information provided here.

 The clinical significance of the information related to the results of clinical trials for each patient should be determined by a physician experienced in treating  the disease or by a relevant healthcare professional. If you have questions about specific symptoms, please consult a physician or a relevant healthcare professional.

 Taisho strives to provide the most up to date information about all the clinical trials listed here. However, the information may not be current depending on the last up date of the website. The results of clinical trials shared here reflect the knowledge obtained as of its completion date. This website do not provide information about the most recent assessments of the drug’s safety or efficacy.

Be sure to understand and agree to our “Term of Uses” before viewing this webpage.

List of the Taisho clinical trials

List of the Taisho clinical trials

(As of April 1, 2025)

(As of April 1, 2025)


For details, see the jRCT or ClinicalTrials.gov.
●: Patient enrollment trial

For details, see the jRCT or ClinicalTrials.gov.
●: Patient enrollment trial

Type 2 diabetes in children

Type 2 diabetes in children

Phase

Status

Clinical trial ID for the registered clinical trial website

jRCT

ClinicalTrials.gov

Phase 3

Active
not recruiting

jRCT2031200244

Phase 1

Completed

jRCT2080223964

Phase

Status

Clinical trial ID for the registered clinical trial website

jRCT

ClinicalTrials.gov

Phase 3

Active
not recruiting

jRCT2031200244

Phase 1

Completed

jRCT2080223964

Hyperphosphatemia

Hyperphosphatemia

Phase

Status

Clinical trial ID for the registered clinical trial website

jRCT

ClinicalTrials.gov

Phase 3

Recruiting

jRCT2031240567

NCT06745531

Phase 2

Recruiting

jRCT2031240568

NCT06745518

 

Phase 1

Recruiting

jRCT2071240113

NCT06837155

 

Phase 1

Recruiting

jRCT2071240112

NCT06837142

 

Phase 1

Recruiting

jRCT2031240681

NCT06849778

Phase 2

Completed

jRCT2031220587

NCT05699239

 

Phase 1

Completed

jRCT2031240318

NCT06596356

 

Phase 1

Completed

jRCT2071210043

NCT04979572

Phase

Status

Clinical trial ID for the registered clinical trial website

jRCT

ClinicalTrials.gov

Phase 3

Recruiting

jRCT2031240567

NCT06745531

Phase 2

Recruiting

jRCT2031240568

NCT06745518

 

Phase 1

Recruiting

jRCT2071240113

NCT06837155

 

Phase 1

Recruiting

jRCT2071240112

NCT06837142

 

Phase 1

Recruiting

jRCT2031240681

NCT06849778

Phase 2

Completed

jRCT2031220587

NCT05699239

 

Phase 1

Completed

jRCT2031240318

NCT06596356

 

Phase 1

Completed

jRCT2071210043

NCT04979572

Insomnia

Insomnia

Phase

Status

Clinical trial ID for the registered clinical trial website

jRCT

ClinicalTrials.gov

Phase 3

Completed

jRCT2031220208

NCT05461352

Phase 3

Completed

jRCT2031220209

NCT05453136

Phase 2

Completed

jRCT2080225269

NCT04469023

 

Phase 1

Completed

jRCT2071230009

NCT05819710

 

Phase 1

Completed

jRCT2071220103

NCT05707897

 

Phase 1

Completed

jRCT2031220463

NCT05624944

 

Phase 1

Completed

jRCT2071210018

NCT04873323

 

Phase 1

Completed

jRCT2031200373

NCT04746105

 

Phase 1

Completed

jRCT2071200075

NCT04696952

 

Phase 1

Completed

jRCT2031210027

NCT04814771

 

Phase 1

Completed

jRCT2071200036

NCT04557163

Phase

Status

Clinical trial ID for the registered clinical trial website

jRCT

ClinicalTrials.gov

Phase 3

Completed

jRCT2031220208

NCT05461352

Phase 3

Completed

jRCT2031220209

NCT05453136

Phase 2

Completed

jRCT2080225269

NCT04469023

 

Phase 1

Completed

jRCT2071230009

NCT05819710

 

Phase 1

Completed

jRCT2071220103

NCT05707897

 

Phase 1

Completed

jRCT2031220463

NCT05624944

 

Phase 1

Completed

jRCT2071210018

NCT04873323

 

Phase 1

Completed

jRCT2031200373

NCT04746105

 

Phase 1

Completed

jRCT2071200075

NCT04696952

 

Phase 1

Completed

jRCT2031210027

NCT04814771

 

Phase 1

Completed

jRCT2071200036

NCT04557163

Rheumatoid arthritis

Rheumatoid arthritis

Phase

Status

Clinical trial ID for the registered clinical trial website

jRCT

ClinicalTrials.gov

Phase 3

Completed

jRCT2080224848

NCT04077567

Phase 3

Completed

jRCT2080223973

Phase 2
/Phase 3

Completed

jRCT2080223971

Phase

Status

Clinical trial ID for the registered clinical trial website

jRCT

ClinicalTrials.gov

Phase 3

Completed

jRCT2080224848

NCT04077567

Phase 3

Completed

jRCT2080223973

Phase 2
/Phase 3

Completed

jRCT2080223971

【Contact】

【Contact】

Use the email address below to submit questions about clinical trial information.

shu_chiken@taisho.co.jp

Use the email address below to submit questions about clinical trial information.

shu_chiken@taisho.co.jp